Boston Scientific To Pay J&J $1.7B In Stent Settlement
Boston Scientific and J&J unit Cordis Corp. said in separate statements Monday that the settlement will avert two jury trials in the U.S. District Court for the District of Delaware on the issue of damages.
The deal is the second major settlement between the companies in four months. Boston Scientific agreed...
To view the full article, register now.